Literature DB >> 27913749

Belimumab in primary antiphospholipid syndrome.

A Yazici1, B Yazirli2, D Erkan3.   

Abstract

Entities:  

Keywords:  Antiphospholipid syndrome; B cell therapy; belimumab

Mesh：

Substances：

Year:  2016        PMID： 27913749     DOI： 10.1177/0961203316682102

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  7 in total

1.  Is there a role for immunosuppression in antiphospholipid syndrome?

Authors:  Ecem Sevim; Rohan Willis; Doruk Erkan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 2.  Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome.

Authors:  Rafid Mustafa
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-30       Impact factor: 6.030

Review 3.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

Review 4.  Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

Authors:  Ilaria Mormile; Francescopaolo Granata; Alessandra Punziano; Amato de Paulis; Francesca Wanda Rossi
Journal:  Biomedicines       Date:  2021-02-01

Review 5.  Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.

Authors:  Maria G Tektonidou
Journal:  Front Immunol       Date:  2018-05-31       Impact factor: 7.561

6.  Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores.

Authors:  Lucas L van den Hoogen; Giovanni Palla; Cornelis P J Bekker; Ruth D E Fritsch-Stork; Timothy R D J Radstake; Joel A G van Roon
Journal:  RMD Open       Date:  2018-07-13

7.  16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Authors:  Hannah Cohen; Maria J Cuadrado; Doruk Erkan; Ali Duarte-Garcia; David A Isenberg; Jason S Knight; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; David J Williams; Rohan Willis; Scott C Woller; Danieli Andrade
Journal:  Lupus       Date:  2020-10       Impact factor: 2.911
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.